Skip to content

ACTINIUM PHARMACEUTICALS, INC.: filings

Every ACTINIUM PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-07fiscal Q2 202634960001213900-26-086769
10-Q2026-05-08fiscal Q1 202633680001213900-26-053980
10-K2026-03-30fiscal FY 202537730001213900-26-036504
10-Q2025-11-14fiscal Q3 202533950001213900-25-110979
10-Q2025-08-08fiscal Q2 202532890001213900-25-073743
10-Q2025-05-09fiscal Q1 202533660001213900-25-041614
10-K2025-03-31fiscal FY 202434680001213900-25-026371
10-Q2024-11-14fiscal Q3 202431940001213900-24-098534
10-Q2024-08-05fiscal Q2 202431900001213900-24-065239
10-Q2024-04-26fiscal Q1 202432670001213900-24-036699
10-K2024-03-29fiscal FY 202334690001213900-24-028038
10-Q2023-11-02fiscal Q3 202333970001213900-23-082459
10-Q2023-08-14fiscal Q2 202331900001213900-23-067199
10-Q2023-05-15fiscal Q1 202332670001213900-23-039902
10-K2023-03-31fiscal FY 202234700001213900-23-025597
10-Q2022-11-14fiscal Q3 202232980001213900-22-072371
10-Q2022-08-12fiscal Q2 202232940001213900-22-047496
10-Q2022-05-13fiscal Q1 202231660001213900-22-026538
10-K2022-03-25fiscal FY 202134670001213900-22-015208
10-Q2021-11-12fiscal Q3 202132880001213900-21-058783
10-Q2021-07-30fiscal Q2 202132820001213900-21-039595
10-Q2021-05-14fiscal Q1 202130600001213900-21-026493
10-K2021-03-31fiscal FY 202031640001213900-21-019297
10-Q2020-10-23fiscal Q3 202030850001213900-20-033053
10-Q2020-08-14fiscal Q2 202029780001213900-20-022334
10-Q2020-06-29fiscal Q1 202028580001213900-20-016168
10-K2020-05-08fiscal FY 201931600001213900-20-011475
10-Q2019-11-12fiscal Q3 201929820001213900-19-022937
10-Q2019-08-09fiscal Q2 201929780001213900-19-015171
10-Q2019-05-10fiscal Q1 201928560001213900-19-008291
10-K2019-03-15fiscal FY 201827710001213900-19-004269
10-Q2018-11-09fiscal Q3 201826690001213900-18-015315
10-Q2018-08-09fiscal Q2 201826680001213900-18-010603
10-Q2018-05-10fiscal Q1 201826540001213900-18-005849
10-K2018-03-16fiscal FY 201727710001213900-18-003091
10-Q2017-11-03fiscal Q3 201727710001213900-17-011347
10-Q2017-08-04fiscal Q2 201727710001213900-17-008244
10-Q2017-05-15fiscal Q1 201727550001213900-17-005183
10-K2017-03-16fiscal FY 201627730001213900-17-002461
10-Q2016-10-28fiscal Q3 201631880001213900-16-017787
10-Q2016-07-29fiscal Q2 201631880001213900-16-015402
10-Q2016-05-10fiscal Q1 201627540001213900-16-013129
10-K2016-03-11fiscal FY 201527730001213900-16-011534
10-Q2015-10-30fiscal Q3 201526680001213900-15-008084
10-Q2015-08-07fiscal Q2 201530840001213900-15-005829
10-Q2015-05-08fiscal Q1 201525500001213900-15-003401
10-K2015-03-16fiscal FY 201427560001213900-15-001800
10-Q2014-10-31fiscal Q3 201428700001213900-14-007643
10-Q2014-08-12fiscal Q2 201431830001213900-14-005682
10-Q2014-05-12fiscal Q1 201424620001213900-14-003153
10-K2014-02-28fiscal FY 2013271090001213900-14-001206
10-Q2013-11-14fiscal Q3 201326790001213900-13-006378
10-Q2013-08-13fiscal Q2 201326790001213900-13-004217
10-Q2013-05-15fiscal Q1 201325840001213900-13-002615
10-K2013-03-29fiscal FY 201226940001213900-13-001417
10-Q2012-11-14fiscal Q3 201226590001078782-12-002804
10-Q/A2012-08-29fiscal Q2 201226540001471242-12-001217
10-Q2012-04-23fiscal Q1 201226530001078782-12-001117
10-K2012-04-12fiscal FY 201126530001078782-12-001008
10-Q2011-11-14fiscal Q3 201121440001445305-11-003418
10-Q2011-08-12fiscal Q2 201121440001445305-11-002499

Inspect the source

Entity
ACTINIUM PHARMACEUTICALS, INC. / CIK 0001388320
Captured
2026-09-20T07:59:08.087Z
SEC response SHA-256
8b2cf9a9df391f2441e59da237c67a180665686e2082a76d5298eb6715d76292

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388320.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))